Evidence map›Paper›PMID 37941524›Full record

ArticleCancer2024

Toward reducing racialized pain care disparities: Approaching cannabis research and access through the lens of equity and inclusion.

Brooke Worster, Salimah H Meghani, Amy E Leader, Shannon M Nugent, Katie Fitzgerald Jones, Katherine A Yeager, Kevin Liou, Rebecca L Ashare

Open access · hybridAbstract read
In one paragraph

Article in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Brooke WorsterSidney Kimmel Cancer Center, Department of Medical Oncology, Jefferson Health, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-6687-1760
Salimah H MeghaniDepartment of Biobehavioral Health Science, School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Amy E LeaderSidney Kimmel Cancer Center, Department of Medical Oncology, Jefferson Health, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-9514-3631
Shannon M NugentDepartment of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA.ORCID 0000-0003-3173-6590
Katie Fitzgerald JonesCenter for Aging and Serious Illness, Massachusetts General Hospital, Boston, Massachusetts, USA.
Katherine A YeagerNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia, USA.
Kevin LiouIntegrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0002-2438-9749
Rebecca L AshareDepartment of Psychology, State University of New York at Buffalo, Buffalo, New York, USA.
Thomas Jefferson University Hospital · USEmory University · USMassachusetts General Hospital · USMemorial Sloan Kettering Cancer Center · USNeurobehavioral Systems · USOregon Health & Science University · USUniversity at Buffalo, State University of New York · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort studyR01CA270483 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Rebecca Ashare, Salimah H. Meghani · 2022 to 2026
$3.5M
Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIVR01CA285331 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Rebecca Ashare, Roger Vilardaga · 2024 to 2026
$1.9M
Acupuncture for Cognitive Health in Older Survivors of Prostate Cancer (ACHIEVE)K08CA266927 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Kevin T Liou · 2022 to 2026
$1.2M
NCI NIH HHS K08 CA266927NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA270483NCI NIH HHS R01 CA285331
6 · The paper itself

Abstract

There is growing interest in cannabis use for cancer pain. This commentary aims to discuss the evidence surrounding cannabis use for cancer pain in the context of the long-racialized landscape of cannabis policies and the disparity in pain control among cancer patients holding minoritized racial identities. Much evidence surrounding both the benefits and harms of cannabis use in cancer patients, and all patients in general, is lacking. Although drawing on the research in cancer that is available, it is also important to illustrate the broader context about how cannabis' deep roots in medical, political, and social history impact patient use and health care policies. There are lessons we can learn from the racialized disparities in opioid risk mitigation strategies, so they are not replicated in the settings of cannabis for cancer symptom management. Additionally, the authors intentionally use the term "cannabis" here rather than "marijuana.: In the early 1900s, the lay press and government popularized the use of the word "marijuana" instead of the more common "cannabis" to tie the drug to anti-Mexican prejudice.

Indexed as

Cancer PainCannabisChronic PainMedical MarijuanaNeoplasmsAnalgesics, OpioidHumansPainAnalgesics, OpioidMedical Marijuanacancercannabishealth inequitiesopioidspain

Identifiers

PMID37941524
PMCPMC11212108
OpenAlexW4388538639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.